FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

25290611000001102: Empagliflozin 25mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Aug 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
80254901000001114 Empagliflozin 25mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
80255001000001114 Empagliflozin 25mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Empagliflozin 25mg tablets Is a Empagliflozin true Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets Is a Empagliflozin false Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets Has specific active ingredient Empagliflozin false Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets Has specific active ingredient Empagliflozin true Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets Is a Product containing empagliflozin false Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets Has active ingredient Empagliflozin false Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Jardiance 25mg tablets (CST Pharma Ltd) Is a True Empagliflozin 25mg tablets Inferred relationship Existential restriction modifier
Jardiance 25mg tablets (Mawdsley-Brooks & Company Ltd) Is a True Empagliflozin 25mg tablets Inferred relationship Existential restriction modifier
Jardiance 25mg tablets (DE Pharmaceuticals) Is a True Empagliflozin 25mg tablets Inferred relationship Existential restriction modifier
Jardiance 25mg tablets (Boehringer Ingelheim Ltd) Is a True Empagliflozin 25mg tablets Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets 28 tablet Has VMP True Empagliflozin 25mg tablets Inferred relationship Existential restriction modifier
Jardiance 25mg tablets (Originalis B.V.) Is a True Empagliflozin 25mg tablets Inferred relationship Existential restriction modifier
Empagliflozin 25mg tablets 30 tablet Has VMP True Empagliflozin 25mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start